DrugPatentWatch Database Preview
Profile for Eurasian Patent Organization Patent: 201290026
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Eurasian Patent Organization Patent: 201290026
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 17, 2031 | Horizon | VIMOVO | esomeprazole magnesium; naproxen |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |